Humana IncHUM
Price$379.68Intrinsic value$367.843% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $6.2B+39.4% YoYTTM through 31 Mar 2026
Net Income $1.1B-6.4% YoYTTM through 31 Mar 2026
Free Cash Flow $1.3BTTM through 31 Mar 2026

Margins

Current
EBITDA Margin50.6%
Operating Margin39.6%
Net Margin18.3%

Returns

6.1%ROE
2.0%ROA
4.1%ROIC

Balance Sheet Health

Debt / Equity0.75x
Current Ratio1.77x
Net Debt$9B
Cash & Equivalents$5B

Quality Metrics

Altman Z-Score2.11
Piotroski F-Score6 / 9
FCF Margin20.6%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $129.7B
Diluted EPS$9.37TTM
'19'20'21'22'23'24'25
FY2025: $9.84

Dividend

$2.66Per share, FY20260.71%Yield-0.5%5-yr growth

Capital Allocation

Capex Intensity9.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.